Le Lézard
Classified in: Health
Subject: ACC

Navamedic ASA: Notification of major shareholding and mandatory notification of trade


OSLO, Norway, March 12, 2024 /PRNewswire/ -- Ingerø Reiten Investment Company AS ("IRIC") has today sold all of its shares in the Nordic pharmaceutical company Navamedic ASA. The shares were sold for 32 kroner per share, for total gross proceeds of approximately NOK 95 million, or about 2.7 times the amount invested. IRIC has been Navamedic's principal owner and strategic partner since 2019. IRIC will use part of the proceeds to strengthen its balance sheet by paying off debt.

"For IRIC this was the right time to sell. Navamedic is a first-class company, but as a large, strategic investor, it is also important to know when to pass the baton to others. We are very pleased to hand over our Navamedic shares to new owners, and with the price we have achieved. The average weighted price during the past 30 day was NOK 37.5 per share," said Terje Bakken, partner at IRIC and chairman of Navamedic.

The shares have been acquired by institutional and private investors, of which several are international investors with a particular interest for pharma.

"Navamedic has had an extraordinary development over the past few years. In 2023, revenues passed the NOK 500 million mark, nearly three times revenues in 2019. It has secured rights to a number of attractive products for sale in the Nordic region and Europe and is also looking at opportunities elsewhere in the world," Bakken continued.

IRIC is controlled by Narve Reiten and a close associate to the chairman Terje Bakken and board member Narve Reiten in Navamedic ASA ("Navamedic"). The number of shares sold today was 2,965,618 shares, equaling approximately 17.1 percent of the share capital and votes in Navamedic, reducing IRIC's holding of shares and votes to zero. IRIC has no other rights to shares in Navamedic.

This disclosure is made pursuant to article 19 of the EU Market Abuse Regulation and sections 4-2 and  5-12 of the Norwegian Securities Trading Act.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/navamedic-asa/r/navamedic-asa--notification-of-major-shareholding-and-mandatory-notification-of-trade,c3944854

The following files are available for download:

https://mb.cision.com/Main/17619/3944854/2664926.pdf

Notification of trade


These press releases may also interest you

at 12:18
DRI Healthcare Trust ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 7, 2024. All of the nominees for election as trustees of the Trust referred to in its management...

at 12:15
Modern Vision Centers (MVC), a revolutionary network of premier optometry, medical ophthalmology, and refractive surgery practices, proudly announces its official debut, offering comprehensive and personalized eye care solutions that set a new...

at 12:10
The rising pediatric mental health crisis has put a strain on emergency departments across the country. "The Development and Implementation of a Pediatric Nursing Emergency Behavioral Health Assessment Tool" in the May issue of the Journal of...

at 12:05
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 12:05
LGI Healthcare Solutions, a Canadian leader in healthcare IT, proudly announces the selection of its LGI Education (MedSIS 3C)...

at 12:00
AlphaLab Health, an accelerator program developed by Innovation Works and Allegheny Health Network for life-sciences startups in the Pittsburgh region, has received a $10 million grant from an anonymous donor to create an evergreen fund. The...



News published on and distributed by: